cagrilintide 5mg+semaglutide 5mg Semaglutide + Blend (Research) Cagrilintide 5mg (Research Only)

Semanext is developed and manufactured under strict international quality controls by Lupin Ltd, a globally trusted leader in pharmaceuticals

are employees and shareholders of Novo Nordisk

According to FDA prescribing information, these effects vary by product and dose: For Ozempic (diabetes treatment): Nausea (15-20% of patients) Diarrhea (8-9% of patients) Vomiting (5-9% of patients) Constipation (3-7% of patients) Abdominal pain (5-6% of patients) For Wegovy (weight management), gastrointestinal effects are more common at the higher therapeutic dose: Nausea (up to 44% of patients) Diarrhea (up to 30% of patients) Vomiting (up to 24% of patients) Constipation (up to 24% of patients) Abdominal pain (up to 20% of patients) These effects are generally mild to moderate and tend to diminish with continued use

Clinical guidance from UK providers suggests that feeling cold is typically an indirect consequence of weight loss and reduced calorie intake, rather than a direct pharmacological effect of the medicine itself

Choose the least busy day of the week According to Dr